doi: 10.1074/jbc.RA120.014368 16 RichardsPParkerHEAdriaenssensAEHodgsonJMCorkSCTrappSet al
However, in June 2026 the Medicines and Healthcare products Regulatory Agency (MHRA) approved the first GLP-1 tablet, oral semaglutide, for weight management and as of 6 July the Wegovy pill is now available for sale in the UK
2024 systematic review/meta-analysis (12 RCTs, n=402): chronic use post-exercise blood-lactate (SMD 0.69 mmol/L) and VO max by 2.2 mL/kg/min
Others get nausea, diarrhea, cramps, or a fishy body odor
In plain terms: the risk is real and label-acknowledged, but it concentrates in people who get dehydrated, not the whole population
Both medications represent important additions to the range of science-based treatment options available, offering different approaches that can support individualized care